Managed Account Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | $945K | Sell |
15,020
-2,384
| -14% | -$150K | ﹤0.01% | 2126 |
|
|
2015
Q1 | $837K | Buy |
17,404
+3,615
| +26% | +$174K | ﹤0.01% | 2141 |
|
|
2014
Q4 | $458K | Buy |
+13,789
| New | +$458K | ﹤0.01% | 2217 |
|
|
2014
Q3 | – | Sell |
-7,574
| Closed | -$294K | – | 2703 |
|
|
2014
Q2 | $294K | Buy |
7,574
+3,292
| +77% | +$128K | ﹤0.01% | 2235 |
|
|
2014
Q1 | $180K | Buy |
+4,282
| New | +$180K | ﹤0.01% | 2251 |
|